Cargando…

Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?

BACKGROUND: Childhood-onset systemic lupus erythematosus (cSLE) is an incurable multi-systemic autoimmune disease. Interferon type I (IFN-I) plays a pivotal role in the pathogenesis of SLE. The objective of this study was to assess the prevalence of the IFN-I signature and the contribution of cytoso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wahadat, M. Javad, Bodewes, Iris L. A., Maria, Naomi I., van Helden-Meeuwsen, Cornelia G., van Dijk-Hummelman, Annette, Steenwijk, Eline C., Kamphuis, Sylvia, Versnel, Marjan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5763828/ https://www.ncbi.nlm.nih.gov/pubmed/29321042 http://dx.doi.org/10.1186/s13075-017-1501-z

Ejemplares similares

Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
por: Wahadat, M Javad, et al.
Publicado: (2022)

LLDAS is an attainable treat-to-target goal in childhood-onset SLE
por: Wahadat, Mohamed Javad, et al.
Publicado: (2021)

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren’s syndrome in the JOQUER randomized trial
por: Bodewes, Iris L A, et al.
Publicado: (2020)

Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study
por: Wahadat, Mohamed Javad, et al.
Publicado: (2023)

T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?
por: Brkic, Zana, et al.
Publicado: (2014)

Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland
por: Wildenberg, Manon E, et al.
Publicado: (2008)

Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study
por: Wahadat, M Javad, et al.
Publicado: (2022)

Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren’s syndrome patients through immunogenetics
por: Kolijn, P. Martijn, et al.
Publicado: (2023)

Dysregulated endothelial cell markers in systemic lupus erythematosus: a systematic review and meta-analysis
por: Bergkamp, S. C., et al.
Publicado: (2023)

Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets
por: Bodewes, Iris L. A., et al.
Publicado: (2019)

Trained Immunity in Primary Sjögren’s Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype
por: Huijser, Erika, et al.
Publicado: (2022)

The Kinetics of Plasmacytoid Dendritic Cell Accumulation in the Pancreas of the NOD Mouse during the Early Phases of Insulitis
por: Welzen-Coppens, Jojanneke M. C., et al.
Publicado: (2013)

The Gene Expression Profile of CD11c(+)CD8α(−) Dendritic Cells in the Pre-Diabetic Pancreas of the NOD Mouse
por: Beumer, Wouter, et al.
Publicado: (2014)

Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren’s syndrome that show potential to predict and monitor clinical response
por: Hamkour, Safae, et al.
Publicado: (2023)

IFN-γ Mediates the Development of Systemic Lupus Erythematosus
por: Liu, Wenping, et al.
Publicado: (2020)

Long-term outcomes in childhood-onset systemic lupus erythematosus: preliminary results of the CHILL-NL study
por: Groot, Noortje, et al.
Publicado: (2014)

Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’ – Authors’ reply
por: Brkic, Zana, et al.
Publicado: (2014)

Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's syndrome and association with disease activity and BAFF gene expression
por: Brkic, Zana, et al.
Publicado: (2013)

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome
por: Maria, Naomi I, et al.
Publicado: (2014)

Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren’s syndrome
por: Huijser, Erika, et al.
Publicado: (2022)

IFN-gamma transgenic mice: clues to the pathogenesis of systemic lupus erythematosus?
por: Seery, John P
Publicado: (2000)

Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients
por: Adel, Yasmin, et al.
Publicado: (2020)

The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
por: Wulffraat, Nico, et al.
Publicado: (2018)

Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
por: Meesilpavikkai, Kornvalee, et al.
Publicado: (2019)

Blood myxovirus resistance protein‐1 measurement in the diagnostic work‐up of suspected COVID‐19 infection in the emergency department
por: Tong‐Minh, Kirby, et al.
Publicado: (2022)

Alternative exon usage in TRIM21 determines the antigenicity of Ro52/TRIM21 in systemic lupus erythematosus
por: Gomez-Bañuelos, Eduardo, et al.
Publicado: (2022)

IFN-I Mediates Dysfunction of Endothelial Progenitor Cells in Atherosclerosis of Systemic Lupus Erythematosus
por: Ding, Xuewei, et al.
Publicado: (2020)

Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren’s syndrome
por: Huijser, Erika, et al.
Publicado: (2021)

The encyclopedia of conspiracies and conspiracy theories /
por: Newton, Michael, 1951-
Publicado: (2006)

Clinical phenotype of neonatal lupus erythematosus relates to autoantibody level and gender
por: Venkatesan, S, et al.
Publicado: (2011)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
por: Oke, Vilija, et al.
Publicado: (2017)

Analysis of growth in female patients with pediatric-onset systemic lupus erythematosus
por: Mak, NC, et al.
Publicado: (2011)

Are conspiracy theorists psychotic? A comparison between conspiracy theories and paranoid delusions
por: Veling, W., et al.
Publicado: (2022)

A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients
por: López, Patricia, et al.
Publicado: (2016)

Antibodies against type I IFN: The bad guys self-restrain in systemic lupus erythematosus
por: Fillatreau, Simon
Publicado: (2023)

Acute myopic shift in a patient with systemic lupus erythematosus
por: Yosar, Jason, et al.
Publicado: (2019)

Blood Genomics Identifies Three Subtypes of Systemic Lupus Erythematosus: “IFN-High,” “NE-High,” and “Mixed”
por: Cui, Mintian, et al.
Publicado: (2021)

AKT2 reduces IFNβ1 production to modulate antiviral responses and systemic lupus erythematosus
por: Zheng, Xin, et al.
Publicado: (2022)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Cannot write session to /tmp/vufind_sessions/sess_csubu05sehp1litkmlu2f3pt8r